Decitabine enhances targeting of aml cells by ny-eso-1-specific tcr-t cells and promotes the maintenance of effector function and the memory phenotype

HIGHLIGHTS

• who: Synat Kang from the Patient samples The use of human materials in this study was approved by the Institutional Review Board of the Shenzhen University General HospitalMononuclear cells from the bone marrow of AML patients or healthy donors were have published the paper: Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype, in the Journal: (JOURNAL) of 12/09/2022
• what: The authors show that the combined use of DAC with highaffinity NY-ESO-1-specific TCR-T_cells . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.